Sep. 21 at 2:17 AM
Looking at a nice week ahead:
$SBEV management stated next CannEpil FDA submission is imminent. Ticker & regulatory pivot, badly beaten down. This gives them a legitimate catalyst to watch for.
$SPRU is criminally undervalued and Friday's price action tells me the market is noticing. I'm here for a 100 to 300% move.
$RKDA earnings improving and a nice sales inflection shaping up. If they've really got their inventory problems behind them it could re-rate back to the .70's. WW.
$RDHL riding a total reset now with a bigger revenue base and improved liquidity. Watching for a climb back to the .80's but not jumping in just yet.
Good luck all.